Literature DB >> 8180030

Platelet-derived growth factor (PDGF) in neoplastic and non-neoplastic cystic lesions of the central nervous system and in the cerebrospinal fluid.

M Nistér1, P Enblad, G Bäckström, T Söderman, L Persson, C H Heldin, B Westermark.   

Abstract

The aim of this study was to determine the concentration of PDGF in vivo in neoplastic and non-neoplastic brain lesions. Fluid from cystic lesions and cerebrospinal fluid was tested in a radioreceptor assay that detects all described PDGF isoforms. High concentration of PDGF were found in cyst fluids from several astrocytomas, one metastatic melanoma, one metastatic lung adenocarcinoma and one intracerebral abscess. The PDGF concentrations were several times higher than the levels known to be required for maximal PDGF effects on cells in vitro. PDGF could also be detected in some non-neoplastic lesions, especially one intracerebral abscess. The finding of high amounts of PDGF in neoplastic lesions strongly supports the possibility that PDGF can be a mediator of tumour and stromal cell growth and motility in vivo. Comparison of PDGF and beta-thromboglobulin concentrations in the same fluids strongly indicates that the PDGF protein is locally produced rather than a result of platelet activation and derangement of the blood-brain barrier.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8180030      PMCID: PMC1968883          DOI: 10.1038/bjc.1994.184

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  36 in total

1.  Platelet-derived growth factor is angiogenic in vivo.

Authors:  W Risau; H Drexler; V Mironov; A Smits; A Siegbahn; K Funa; C H Heldin
Journal:  Growth Factors       Date:  1992       Impact factor: 2.511

2.  PDGF B-chain in neurons of the central nervous system, posterior pituitary, and in a transgenic model.

Authors:  M Sasahara; J W Fries; E W Raines; A M Gown; L E Westrum; M P Frosch; D T Bonthron; R Ross; T Collins
Journal:  Cell       Date:  1991-01-11       Impact factor: 41.582

3.  Immunohistochemical demonstration of serum proteins in human cerebral gliomas.

Authors:  R J Seitz; W Wechsler
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

4.  beta-Thromboglobulin--a specific marker of in-vivo platelet release reaction.

Authors:  J Zahavi; V V Kakkar
Journal:  Thromb Haemost       Date:  1980-08-29       Impact factor: 5.249

5.  Demonstration of an antibody against platelet-derived growth factor.

Authors:  C H Heldin; B Westermark; A Wasteson
Journal:  Exp Cell Res       Date:  1981-12       Impact factor: 3.905

6.  Studies of the release from human platelets of the growth factor for cultured human arterial smooth muscle cells.

Authors:  L D Witte; K L Kaplan; H L Nossel; B A Lages; H J Weiss; D S Goodman
Journal:  Circ Res       Date:  1978-03       Impact factor: 17.367

7.  Rat brain capillary endothelial cells express functional PDGF B-type receptors.

Authors:  A Smits; M Hermansson; M Nistér; I Karnushina; C H Heldin; B Westermark; K Funa
Journal:  Growth Factors       Date:  1989       Impact factor: 2.511

8.  Somatomedins in tumour cyst fluid, cerebrospinal fluid, and tumour cytosol in patients with glial tumours.

Authors:  P Prisell; L Persson; J Boethius; V Sara
Journal:  Acta Neurochir (Wien)       Date:  1987       Impact factor: 2.216

9.  A glioma-derived PDGF A chain homodimer has different functional activities from a PDGF AB heterodimer purified from human platelets.

Authors:  M Nistér; A Hammacher; K Mellström; A Siegbahn; L Rönnstrand; B Westermark; C H Heldin
Journal:  Cell       Date:  1988-03-25       Impact factor: 41.582

10.  Thymidine kinase in brain-tumor cysts.

Authors:  L Persson; J Boethius; J S Gronowitz; C Källander; L Lindgren
Journal:  J Neurosurg       Date:  1985-10       Impact factor: 5.115

View more
  6 in total

Review 1.  New prospects for management and treatment of inoperable and recurrent skull base meningiomas.

Authors:  Mahlon D Johnson; Burak Sade; Michael T Milano; Joung H Lee; Steven A Toms
Journal:  J Neurooncol       Date:  2007-07-12       Impact factor: 4.130

2.  Phase II study of Gleevec plus hydroxyurea in adults with progressive or recurrent low-grade glioma.

Authors:  David A Reardon; Annick Desjardins; James J Vredenburgh; James E Herndon; April Coan; Sridharan Gururangan; Katherine B Peters; Roger McLendon; Sith Sathornsumetee; Jeremy N Rich; Eric S Lipp; Dorothea Janney; Henry S Friedman
Journal:  Cancer       Date:  2012-02-27       Impact factor: 6.860

3.  Migration of human glioma cells in response to tumour cyst fluids.

Authors:  A Giese; F Schröder; A Steiner; M Westphal
Journal:  Acta Neurochir (Wien)       Date:  1996       Impact factor: 2.216

4.  Cerebrospinal fluid stimulates leptomeningeal and meningioma cell proliferation and activation of STAT3.

Authors:  Mahlon D Johnson; Mary O'Connell; Michael Facik; Paul Maurer; Babak Jahromi; Webster Pilcher
Journal:  J Neurooncol       Date:  2011-10-05       Impact factor: 4.130

5.  Prognostic value of platelet derived growth factor alpha receptor expression in grade 2 astrocytomas and oligoastrocytomas.

Authors:  D Ribom; J Andrae; M Frielingsdorf; M Hartman; M Nistér; A Smits
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-06       Impact factor: 10.154

Review 6.  R Regulation of tumor angiogenesis and metastasis by FGF and PDGF signaling pathways.

Authors:  Yihai Cao; Renhai Cao; Eva-Maria Hedlund
Journal:  J Mol Med (Berl)       Date:  2008-04-08       Impact factor: 4.599

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.